Search results for "philia"

showing 10 items of 299 documents

HLA genotype in patients with acquired haemophilia A

2010

Acquired haemophilia A (AH) is a rare bleeding disorder caused by an auto-antibody to coagulation factor VIII. It is associated with various autoimmune diseases, pregnancy, cancer or drug ingestion; however, in 50% of patients, no underlying disorder is found. In the present study, we investigated the association of HLA class I (A, B and Cw) and class II (DRB1 and DQB1) alleles with AH in a cohort of 57 patients. While no association with any class I allele was detected, a significantly higher frequency of DRB1*16 [odds ratio (OR) 10.2, 95%CI: 5.32-19.57, P < 0.0001] and DQB1*0502 (OR 2.2, 95%CI: 1.12-4.54, P < 0.05) was observed. In contrast, the frequency of DRB1*15 and DQB1*0602 alleles …

business.industryHaplotypeHaemophilia AHematologyGeneral MedicineOdds ratioHuman leukocyte antigenmedicine.diseaseAntigenGenotypeImmunologyMedicineAllelebusinessAllele frequencyGenetics (clinical)Haemophilia
researchProduct

Pulmonary Eosinophilia Caused by Testosterone Cypionate

2013

business.industryImmunologyMedicineGeneral MedicinebusinessPulmonary EosinophiliaArchivos de Bronconeumología (English Edition)
researchProduct

Sexual Deviation and Paraphilias

2006

chemistry.chemical_compoundSexual dysfunctionchemistrySexual arousalmedicineCyproterone acetateParaphiliamedicine.symptomPsychologymedicine.diseaseClinical psychology
researchProduct

Inducing Cold-Sensitivity in the Frigophilic Fly Drosophila montana by RNAi

2016

The work was supported by CNPq (Fellowship to FMV) and a NERC Studentship to DJP. Cold acclimation is a critical physiological adaptation for coping with seasonal cold. By increasing their cold tolerance individuals can remain active for longer at the onset of winter and can recover more quickly from a cold shock. In insects, despite many physiological studies, little is known about the genetic basis of cold acclimation. Recently, transcriptomic analyses in Drosophila virilis and D.montana revealed candidate genes for cold acclimation by identifying genes upregulated during exposure to cold. Here, we test the role of myo-inositol-1-phosphate synthase (Inos), in cold tolerance in D. montana …

cold-sensitivityQH301 Biologycold acclimationselviytyminenlcsh:Rfungilcsh:MedicineQH426 Geneticscold toleranceseasonal coldThermal adaptationQH301RNAitalvihyönteisetlcsh:Qlcsh:ScienceDrosophiliaQH426
researchProduct

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A

2017

Introduction: The administration of factor VIII (FVIII) concentrates on-demand or on long-term prophylaxis is the effective and safe standard of care of patients with hemophilia A (HA). Development of neutralizing antibodies against exogenous FVIII and the short half-life of the current available products remain major challenges. There is currently a great interest towards newer FVIII products with the goal of reducing the inhibitor risk and increasing the half-life. Area covered: In this review, the authors describe the efficacy and safety of rVIII-SingleChain (Lonoctocog alfa), the first and only single chain recombinant FVIII (rFVIII) molecule developed for the prevention and treatment o…

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyHaemophiliaStandard of caresingle-chainHaemophilia AClinical BiochemistrySingle chain030204 cardiovascular system & hematologyHaemophiliaHemophilia A03 medical and health sciences0302 clinical medicineLONOCTOCOG ALFAhemic and lymphatic diseasesDrug DiscoverymedicineHumansPharmacologyClinical Trials as TopicFactor VIIIbusiness.industryCoagulantsDrug Discovery3003 Pharmaceutical ScienceRecombinant Proteinmedicine.diseaseRecombinant ProteinsCoagulantbusiness030215 immunologyHalf-LifeHuman
researchProduct

Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice

2013

Hemophilia defines a group of hereditary bleeding disorders: hemophilia A (deficiency of Factor VIII, FVIII), hemophilia B (deficiency of FIX), and para-hemophilia (deficiency of FV). These result from mutations in clotting factor genes. As in the large majority of bleeding disorders ([Table 1][1

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyTime FactorsLong term treatmentBlood transfusionmedicine.medical_treatmentTreatment outcomeEditorials and PerspectivesHemophilia AHemorrhagic DisordersHemorrhagic disorderhemic and lymphatic diseasesBlood-Borne PathogensmedicineHumansBlood TransfusionPathogenClotting factorbusiness.industryHematologyRecombinant ProteinsTreatment OutcomeCurrent practiceImmunologybusiness
researchProduct

Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting

2021

Abstract Introduction For persons with hemophilia, optimization of joint outcomes is an important unmet need. The aim of this initiative was to determine use of ultrasound in evaluating arthropathy in persons with hemophilia, and to move toward consensus among hemophilia care providers regarding the preferred ultrasound protocols for global adaptation. Methods A global survey of hemophilia treatment centers was conducted that focused on understanding how and why ultrasound was being used and endeavored to move toward consensus definitions of both point‐of‐care musculoskeletal ultrasound (POC‐MSKUS) and full diagnostic ultrasound, terminology to describe structures being assessed by ultrasou…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDiagnostic ultrasoundMusculoskeletal ultrasoundUnmet needsTerminologysurveyshemic and lymphatic diseaseshemophiliaHealth careMedicineImage acquisitionMedical physicsDiseases of the blood and blood-forming organsClinical caremusculoskeletalbusiness.industryOriginal ArticlesHematologyultrasonographyconsensus hemophilia musculoskeletal surveys ultrasonographyconsensusOriginal ArticlePatient representativesRC633-647.5businessResearch and Practice in Thrombosis and Haemostasis
researchProduct

A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/Humate -P: history and clinical performance

2008

Patients with von Willebrand disease (VWD) and haemophilia A (HA) lack, to varying degrees, the von Willebrand factor (VWF) and coagulation factor VIII (FVIII) that are critical for normal haemostasis. These conditions in turn make patients prone to uncontrolled bleeding. Historically, patients with severe forms of VWD or HA were crippled before adulthood and their life expectancy was significantly reduced. Over the past decades, specific coagulation factor replacement therapies including Haemate P, have been developed to help patients achieve and maintain normal haemostasis. Haemate P is a human, plasma-derived VWF/FVIII medicinal product, which was first licensed in Germany in 1981 for th…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyHaemophilia AHemophilia AHaemophiliaHaemate P; Humate-P; von Willebrand disease; von Willebrand factor; haemophilia; factor VIIIVon Willebrand factorhemic and lymphatic diseasesInternal medicinevon Willebrand FactormedicineVon Willebrand diseaseHumansDosingDesmopressinHematologybiologybusiness.industryHematologyGeneral Medicinemedicine.diseasevon Willebrand DiseasesCoagulationImmunologybiology.proteinSafetybusinessSettore MED/15 - Malattie del Sanguemedicine.drug
researchProduct

Results of a Prospective, Open-Label Trial to Assess the Efficacy, Safety and Immunogenicity of Wilate® in Children Under 6 Years of Age with Inherit…

2011

Abstract Abstract 3330 Introduction: Wilate® is a new-generation plasma-derived concentrate of von Willebrand factor (VWF) and factor VIII (FVIII) developed for treatment of patients with von Willebrand disease (VWD) and haemophilia A. The objective of this study was to assess efficacy, safety and immunogenicity of Wilate in children below 6 years of age with inherited VWD. Methods: The prospective, multi-centre trial included patients with inherited VWD of any type below 6 years of age with insufficient response to DDAVP. Any clinical event requiring VWF/FVIII concentrate treatment within 1 year was treated with Wilate. Efficacy was recorded by using a 4-point VRS and in vivo recovery of F…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsbiologybusiness.operationbusiness.industryImmunogenicityImmunologyCell BiologyHematologyHaemophiliamedicine.diseaseOctapharmaBiochemistryVon Willebrand factorTolerabilityhemic and lymphatic diseasesInternal medicinemedicinebiology.proteinVon Willebrand diseaseDosingbusinessAdverse effectBlood
researchProduct

Philia, eros e la dinamica della generazione. Euripide, fr. 898 Kannicht nel libro ottavo dell'Etica Nicomachea di Aristotele (1155b 2-4)

2020

Tra gli esempi di philia tra contrari, Aristotele (EN 1155b) cita un frammento drammatico (Eur. fr. 898 Kannicht) con l’immagine cosmologica della generazione ad opera del Cielo, che feconda la Terra con la pioggia. A partire dal frammento, nell’ambito della disamina sulla philia nell'Etica Nicomachea, e alla luce della teoria della generazione in Generazione degli Animali, e dell’inferiorità e passività naturale della femmina rispetto al maschio, l’articolo analizza la relazione tra uomo e donna, che è estranea all’ethos e preesiste alla politica. Among examples of philia between contraries, Aristotle (EN 1155b) cites a dramatic fragment (Eur. fr. 898 Kannicht) with the cosmological image …

femalemalemaschiogenerationpoliticaphiliapolitics.generazioneethofemminaSettore L-FIL-LET/02 - Lingua E Letteratura Greca
researchProduct